Researcher works to understand how gonorrhea develops resistance to antibiotics

Steadily and relentlessly, the bacterium that causes gonorrhea has slipped past medicine’s defenses, acquiring resistance to once-reliable drugs, including penicillin, tetracycline, and ciprofloxacin. These former stalwarts are no longer used to treat the sexually transmitted disease. In 2010, after some…

Dartmouth receives $12.5 million grant to establish Center for Quantitative Biology

Dartmouth’s Geisel School of Medicine has been awarded a 5-year, $12.5 million grant from the National Institutes of Health (NIH) to establish a Center for Quantitative Biology (CQB) that will bring together and enhance initiatives in computational biology, bioinformatics, and…

Genetic redundancy aids competition among bacteria in symbiosis with squid

The molecular mechanism used by many bacteria to kill neighboring cells has redundancy built into its genetic makeup, which could allow for the mechanism to be expressed in different environments. Some strains of luminescent bacteria that compete to colonize the…

Immune cells drive gallstone formation

Sticky meshworks of DNA and proteins extruded by white blood cells called neutrophils act as the glue that binds together calcium and cholesterol crystals during gallstone formation, researchers in Germany report August 15 in the journal Immunity . Both genetic…

New drug targets early instigator of Alzheimer’s disease

Over a hundred years after they were first identified, two ominous signposts of Alzheimer’s disease (AD) remain central topics of research–both formed by sticky accumulations of protein in the brain. Amyloid beta solidifies into senile plaques, which congregate in the…

Findings shed new light on why Zika causes birth defects in some pregnancies

One thing is clear when it comes to Zika: pregnant women must do everything they can to avoid getting infected. If the virus gains entry to the mother’s cells, it can also infect the baby and cause severe birth defects,…

New proteomics technique gives insights into ubiquitin signalling

Australian researchers are among the first in the world to have access to a new approach to understand intricate changes that control how proteins function in our cells in health and disease. The new proteomics technique called ‘ubiquitin clipping’ allows…

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.